|
|
Legal status
Patent not validated
| (51) | INT.CL. | A01N 37/10 | |
| C07C 39/17 | |||
| C07C 213/08 | |||
| C07C 59/60 | |||
| C07C 59/72 | |||
| C07C 39/12 | |||
| C07C 405/00 | |||
| C07C 51/08 | |||
| C07C 51/41 |
| (11) | Number of the document | 2252570 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08861602.4 |
| Date of filing the European patent application | 2008-12-12 | |
| (97) | Date of publication of the European application | 2010-11-24 |
| (45) | Date of publication and mention of the grant of the patent | 2017-04-05 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/013686 |
| Date | 2008-12-12 |
| (87) | Number | WO 2009/078965 |
| Date | 2009-06-25 |
| (30) | Number | Date | Country code |
| 14232 P | 2007-12-17 | US |
| (72) |
BATRA, Hitesh, US
TULADHAR, Sudersan, M., US
PENMASTA, Raju, US
WALSH, David, A., US
|
| (73) |
United Therapeutics Corporation,
1040 Spring Street Silver Spring, Maryland 20910,
US
|
| (54) | AN IMPROVED PROCESS TO PREPARE TREPROSTINIL, THE ACTIVE INGREDIENT IN REMODULIN |
| AN IMPROVED PROCESS TO PREPARE TREPROSTINIL, THE ACTIVE INGREDIENT IN REMODULIN |